InvestorsHub Logo
Followers 51
Posts 9111
Boards Moderated 1
Alias Born 10/25/2007

Re: None

Wednesday, 10/19/2022 8:13:55 AM

Wednesday, October 19, 2022 8:13:55 AM

Post# of 13489
90-DAY ANALYSIS SHOWS MODERNA’S OMICRON BA.1-TARGETING BIVALENT VACCINE, MRNA-1273.214, DEMONSTRATES SUPERIOR ANTIBODY RESPONSE AS FOURTH BOOSTER COMPARED TO SPIKEVAX PROTOTYPE BOOSTER

https://investors.modernatx.com/news/news-details/2022/90-Day-Analysis-Shows-Modernas-Omicron-BA.1-Targeting-Bivalent-Vaccine-mRNA-1273.214-Demonstrates-Superior-Antibody-Response-as-Fourth-Booster-Compared-to-Spikevax-Prototype-Booster/default.aspx
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MRNA News